Selvedge Venture — Full Portfolio

Avro Life Sciences develops platform technology for novel drug delivery through passive transdermal administration.

BiotechHealthtechMedical DevicesWaterloo, CA

SLShak Lakhani(Founder)inKSKeean Sarani(Founder)in

Co-investorsCRCreative Destruction Lab (CDL)EMEmbark VenturesFIFifty YearsGAGarage CapitalHEHeuristic Capital PartnersJUJude Gomila+10 more

Selvedge Venture is a venture capital firm that invests in Pre-Seed, Seed and Series A startups working to address age-related medical conditions, focusing on metabolic syndrome, cancer and neurodegenerative diseases.

AI & Machine LearningBiotechHealthtech

BIOS develops neural digital therapy technology to deliver treatments for neurological conditions.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesCambridge, GB

OAOliver Armitage(Founder)inEHEmil Hewage(Director)in

Co-investorsFIFifty YearsFOFOUNDER.orgHEHeuristic Capital PartnersKEKern Venture GroupTHThe Venture CollectiveY Y Combinator+6 more

MIT is an educational and research institution in Cambridge, Massachusetts, pursuing teaching, research, and innovation across science, engineering, and other fields.

BiotechEdTechCambridge, US

Co-investorsBEBeyond Earth VenturesFLFlagship PioneeringFOFoundersX VenturesJIJIMCOLALair East LabsMAMassChallenge Mexico

Carbometrics is developing i-CAM, a continuous metabolic monitor for cardiopulmonary bypass and organ perfusion circuits used in medical procedures.

HardwareHealthtechMedical Devices

Co-investorsADAda VenturesSCScience Creates Ventures

Exogene is a techbio startup using a generative AI and deep learning platform to discover novel, high-affinity TCR-based (T-cell receptor) therapies for treating solid tumors.

AI & Machine LearningBiotechDeep TechHealthtechOxford, GB

FPFederico Paoletti(CEO & Co-Founder)inAMAndrea Mambrini(CTO & Co-Founder)in

Co-investorsBEBeresford VenturesENEntrepreneur FirstJUJude GomilaUNUnruly CapitalCACambridge Angels groupNANadav Rosenberg+1 more

Kytopen develops non-viral gene delivery technology called Flowfect that combines fluid flow with electric fields to deliver payloads such as mRNA, DNA, and CRISPR Cas9 RNP into cells for high-throughput transfection.

BiotechDeep TechHardwareCambridge, US

CBCullen Buie(Founder; Board Observer)inPGPaulo Garcia(Founder)inMCMichael Chiu(Chief Executive Officer)in

BoardPMPaxton Major(Director)inADAnn DeWitt(Director)inPaul Wotton(Director)

Co-investorsBABantam GroupHOHorizons VenturesMAMassVenturesTBTBD AngelsTETelegraph Hill PartnersTHThe Engine Ventures+2 more

LabCentral is an incubator and shared laboratory facility for early-stage life science startups, offering wet lab space, core facilities, business support programs, and a network of scientific and entrepreneurial resources.

BiotechDeep TechImpact & Social GoodCambridge, US

DARA's Result Interpretation Module provides a digitalized workflow that replaces manual document handling processes for specialists, eliminating printing, scanning, email distribution, and courier services in healthcare result management.

AI & Machine LearningBiotechDigital HealthHealthtech

Dr Andrew Wu(Co-Founder and CEO)Arsen Batagov(Co-Founder)inAndrew Wu(Founder)

Co-investorsELElev8.vcEAEast Ventures

Multiomic Health applies systems biology and data science to omics datasets for drug discovery and development in cardiometabolic and related diseases, working through R&D partnerships with biopharma organizations.

AI & Machine LearningBiotechDigital HealthLondon, GB

RTRobert Thong(Co-founder & CEO)inATAlasdair Thong(Co-founder & Non-Executive Director)inCSCelia Schell(Chief Clinical Officer & Chief Operating Officer)inMSMichael Sierra(Chief Scientific Officer)inACAriella Cohain(Chief Technology Officer)inEBEsra Berkol(Chief of Staff)in

Co-investorsFIFifty YearsHOHoxton VenturesMMMMC VenturesVEVerve VenturesADAda Ventures

Liver transplant and drug testing

Co-investorsAHah! VenturesKHKhosla VenturesLILifeforce CapitalNONorrsken VC

Ochre Bio develops RNA therapeutics and drug discovery platforms targeting liver disease, combining proprietary human liver datasets with AI-driven causal prediction and human tissue validation models.

AI & Machine LearningBiotechHealthtechMedical DevicesLondon, GB

QWQuin Wills(CSO)inJOJack O'Meara(Founder)in

BoardChinwe UkomaduElaine SullivanEliot ForsterJack Castle

Co-investorsBABackedBEBeast VenturesCOCoastCapENEntrepreneur FirstEXExpaGAGaingels+18 more

Oxford Medical Products develops medical devices, drawing on a team of biotech entrepreneurs, material scientists, polymer chemists and medical device engineers.

BiotechDigital HealthHealthtechMedical DevicesOxford, GB

Co-investorsOXOxford Investment Opportunity Network (OION)ADAda Ventures

The Royal Society of Chemistry is a professional membership organisation that connects the global chemistry community through partnerships, conferences, networks and publications.

BiotechClimate TechEdTechEnergyImpact & Social GoodMedia & EntertainmentLondon, GB

Thomas Graham(First President)

Sanome develops AI-powered clinical decision support that helps hospital clinical teams understand patients and detect deterioration earlier, integrating within existing electronic patient record systems.

AI & Machine LearningDigital HealthMedical Devices

Benedikt

Co-investorsHEHeal Capital

Wiley is a publishing and digital solutions company that provides content, tools, and services to academic institutions, research libraries, government agencies, healthcare systems, and journal publishers.

Data & InfrastructureEdTechEnterprise SoftwareMedia & Entertainment